In one study, about 17% of participants receiving cagrilintide alone reported redness, swelling, or discomfort at the injection sitecompared with about 3% of those receiving semaglutide
Eczema, or atopic dermatitis , is a chronic inflammatory skin condition characterized by episodic flares of pruritus, erythema, scaling, and lichenification
Injection risks include infection at the injection site, incorrect dosing, and use of non-sterile preparations
Using a cecal ligation and puncture (CLP) murine model, in vitro microglia-neuron co-cultures, data-independent acquisition (DIA) proteomics and liquid chromatography-mass spectrometry (LC-MS) metabolomics, SAE neuropathology and phenotypes were characterized